🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Inactivated influenza vaccine

Found 715 matching trials

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

The purpose of this study is to determine how children with a history of se...

Status

Completed

Location

University of California, Los Angeles

Start Date

2004-10

Trial ID

NCT01713855

Treatments Being Tested

Inactivated Trivalent Influenza vaccine

Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.

PHASE4

This is a prospective, Open label randomized study. A total of 220 adults a...

Status

Completed

Location

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University,

Start Date

2013-11

Trial ID

NCT02101749

Treatments Being Tested

trivalent inactivated influenza

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

PHASE4

The overall aim of this project is to evaluate the immunogenicity of TIV va...

Status

Completed

Location

Nrf/Dst Vpd Rmpru

Start Date

2013-05

Trial ID

NCT01812980

Treatments Being Tested

Trivalent Inactivated Influenza Vaccine

H3N2 M2SR in Pediatric Population

PHASE1

This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...

Status

Completed

Location

Saint Louis University - Center for Vaccine Development

Start Date

2018-08-15

Trial ID

NCT03553940

Treatments Being Tested

Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine Placebo Quadrivalent MDCK Inactivated Influenza Vaccine

Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

PHASE3

Comparative trial of tolerability, reactogenicity, safety and immunogenicit...

Status

Completed

Location

LLC "Energiya zdorov'ya"

Start Date

2021-02-16

Trial ID

NCT05470582

Treatments Being Tested

Flu-M, Inactivated split influenza vaccine 0.5 mL Vaxigrip, Inactivated split influenza vaccine 0.5 mL Flu-M, Inactivated split influenza vaccine 0.25 mL Vaxigrip, Inactivated split influenza vaccine 0.25 mL

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

PHASE2

Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...

Status

Completed

Location

Radboud University

Start Date

2021-09-20

Trial ID

NCT05082688

Treatments Being Tested

Herpes zoster vaccination (Shingrix, GSK)Influenza Vaccine (Fluarix Tetra Northern Hemisphere 2021 or 2022, GSK)Placebo

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

PHASE2

Primary Objective: To evaluate for each influenza strain the non-inferiori...

Status

Completed

Location

Multiple Locations

Start Date

2006-10

Trial ID

NCT00391391

Treatments Being Tested

Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

PHASE3

The aim of this study is to assess the immunogenicity, safety and reactogen...

Status

Completed

Location

GSK Investigational Site

Start Date

2022-10-14

Trial ID

NCT05568797

Treatments Being Tested

RSVPreF3 OA vaccine FLU vaccine

Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)

N/A

This is an open label, pilot, observational, prospective study of the safet...

Status

Completed

Location

Baylor Institute for Immunology Research

Start Date

2013-09

Trial ID

NCT02006784

Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

PHASE1

This study may provide safety information on a flu vaccine given to childre...

Status

Completed

Location

UCLA Center For Vaccine Research

Start Date

2007-02

Trial ID

NCT00402649

Treatments Being Tested

Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

Previous Next